The 2nd International Ferticlinic Fertility & IVF Conference (2nd IFFIC) concluded in Abu Dhabi, marking a premier global scientific event that underscores the emirate's position as a leading international hub for reproductive medicine and advanced fertility care. On its first day, the conference drew more than 2,000 visitors and featured over 65 international speakers, including leading experts, physicians, policymakers, researchers, and healthcare leaders, who gathered to discuss the future of fertility treatments and medical innovation, and to promote the principles of patient-centered healthcare. Themed “Abu Dhabi Leads the World in IVF Excellence”, the conference reflects the emirate's rapid progress in assisted reproductive technologies, underpinned by strong clinical outcomes, robust regulatory frameworks, and a forward-looking vision grounded in scientific research, innovation, and ethical practice, positioning Abu Dhabi at the forefront of global fertility innovation. The conference agenda presents a comprehensive and forward-thinking program that blends scientific excellence with practical insight. The conference attracted international delegates, speakers, and decision-makers from around the world, reinforcing Abu Dhabi's position as a global capital for IVF excellence and medical tourism. At the conclusion of its proceedings, the IFFIC announced the results of its scientific research competition in impregnation and fertility technologies. Fourth place was shared by the researcher Dr. Binh Vu Thanh and Dr. Thanh Dao Huy. Commenting on this initiative, Dr. Nagwan Ahmed, Conference President, said: “The competition represents a core pillar of the International Ferticlinic Conference's vision, which seeks to transform Abu Dhabi from an advanced treatment hub into a global platform for knowledge creation, scientific research, and innovation in fertility and reproductive medicine, by strengthening partnership between the healthcare sector and academic and research institutions.” For his part, Dr. Elsamawal El Hakim, Chief Executive Officer and Medical Director of the Ferticlinic Group, emphasized that supporting young talent and scientific research represents a long-term strategic investment that contributes to the development of innovative and sustainable solutions, while reinforcing the UAE's position, particularly Abu Dhabi, as a global reference hub for IVF technologies, medical education, and medical tourism. The two-day conference concluded with scientific recommendations underscoring the importance of continued international knowledge exchange, expanded research collaboration, and the adoption of the latest medical innovations within well-established ethical and regulatory frameworks, supporting the future of fertility care at both regional and global levels. The IFFIC saw broad participation, featuring more than 65 international speakers and drawing thousands of physicians, researchers, and stakeholders from across the fertility sector. This conference is designed not only to showcase scientific excellence but also to foster global collaboration, support scientific research, and help shape the future of IVF through innovation, ethical practices, and patient-centered care. The emirate has emerged as a preferred global destination for fertility treatment, combining advanced medical infrastructure with internationally aligned standards and multicultural expertise. The 2nd IFFIC further supports Abu Dhabi's ambition to evolve beyond a treatment destination into a global knowledge and innovation hub for reproductive medicine, strengthening collaboration among healthcare providers, academic institutions, researchers, and policymakers. The 2nd International Ferticlinic Fertility & IVF Conference (2nd IFFIC) concluded in Abu Dhabi after two days of in-depth scientific dialogue, panel discussions, and hands-on educational sessions, bringing together leading global experts, healthcare leaders, and decision-makers. Designed as a global forum for the exchange of knowledge and expertise, the conference brings together leading experts, physicians, and policymakers to address the most pressing challenges and emerging opportunities in fertility care. Through this scientific gathering, we aim to further solidify Abu Dhabi's position as a global benchmark in IVF, research, and fertility education, while contributing to the advancement of sustainable healthcare both locally and internationally. Abu Dhabi's leadership in IVF is driven by an integrated healthcare ecosystem that prioritizes patient safety, quality outcomes, data transparency, and continuous innovation. It also highlighted the growing role of artificial intelligence and advanced technologies in improving treatment outcomes, enhancing patient safety, and reinforcing patient-centered healthcare. The competition drew strong participation from physicians and university students across the UAE, including Khalifa University, the University of Sharjah, and Ras Al Khaimah University, alongside several leading academic institutions. The competition aimed to inspire young researchers to engage early in scientific research and stimulate innovation in reproductive medicine. Over the two days, participants will engage in interactive sessions with leading fertility experts in reproductive medicine, exploring the latest clinical advances and taking part in hands-on learning experiences that reflect the rapidly evolving landscape of fertility care and medical innovation. The program features a series of high-level keynote sessions delivered by national and international health leaders who have contributed to shaping the future of healthcare and medical innovation. It also includes in-depth scientific sessions addressing advances in IVF, fertility preservation, genetics, fetal medicine, and the management of complex reproductive cases. Participants discussed the latest advances in assisted reproductive technologies, fertility preservation, fetal medicine, genetics, and complex reproductive cases. In addition, the conference will host focused discussions on the role of artificial intelligence (AI) in fertility care, examining both its promising opportunities and the most pressing challenges associated with its application. Ahead of the main conference, IVF experts and clinicians participated in hands-on workshops on ultrasound, fetal medicine, and colposcopy. Dr. Elsamawal El Hakim, Chief Executive Officer and Medical Director of the Ferticlinic Group, said: “Abu Dhabi has succeeded in building an integrated health ecosystem that combines clinical excellence, strong regulatory governance, innovation, and an enhanced patient experience.” Building on the success of its inaugural edition, the second conference expands its international reach, deepens its scientific content, and strengthens its strategic global impact. Winning studies were honored and awarded valuable financial prizes in support of their academic and research careers, reflecting a firm commitment to preparing a new generation of scientists and researchers capable of shaping the future of this vital sector. The competition saw Khalifa University secure first place, with Dr. Yassin Al Mahi, a student at the university, receiving the top award. Second place went to Dr. Nigar Mehtiyeva from the University of Ras Al Khaimah, followed by Dr. Arwa Ibrahim, also from the University of Ras Al Khaimah, in third place.
